CRIS Current Research Information System

BALDAZZI, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.858
EU - Europa 3.176
AS - Asia 1.982
AF - Africa 225
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 11
OC - Oceania 7
Totale 9.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.832
GB - Regno Unito 990
VN - Vietnam 830
SE - Svezia 625
CN - Cina 548
IT - Italia 418
DE - Germania 374
SG - Singapore 268
IN - India 173
IE - Irlanda 137
FR - Francia 132
RU - Federazione Russa 96
UA - Ucraina 81
TG - Togo 79
EE - Estonia 68
ZA - Sudafrica 67
CH - Svizzera 53
BG - Bulgaria 51
JO - Giordania 50
FI - Finlandia 44
NG - Nigeria 40
GR - Grecia 37
IR - Iran 37
CI - Costa d'Avorio 34
BE - Belgio 29
CA - Canada 25
EU - Europa 21
TR - Turchia 13
JP - Giappone 8
PL - Polonia 8
AU - Australia 7
HK - Hong Kong 7
UZ - Uzbekistan 7
AT - Austria 6
BR - Brasile 6
KR - Corea 6
ID - Indonesia 5
LB - Libano 5
SC - Seychelles 5
ES - Italia 4
PH - Filippine 4
RO - Romania 4
CL - Cile 3
HR - Croazia 3
MK - Macedonia 3
NL - Olanda 3
TW - Taiwan 3
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
Totale 9.281
Salva come PNG Salva come JPEG
Città #
Southend 935
Dong Ket 589
Chandler 470
Fairfield 417
Ashburn 262
Ann Arbor 257
Houston 237
Wilmington 235
Singapore 216
Seattle 200
Woodbridge 196
Princeton 165
Cambridge 153
Dublin 137
Beijing 97
Nanjing 80
Lomé 79
Westminster 78
Padova 71
Bologna 69
New York 63
Medford 55
Amman 50
Berlin 50
Santa Clara 48
Sofia 48
Bern 46
Abeokuta 39
Bremen 39
Shenyang 36
Abidjan 34
Jinan 34
Saint Petersburg 34
Boardman 32
Hebei 31
Helsinki 29
Nanchang 29
Turin 29
Brussels 28
Jacksonville 23
Changsha 22
Florence 22
San Diego 22
Milan 21
Redwood City 21
Falls Church 19
Hangzhou 17
Mountain View 17
Paris 17
Guangzhou 15
Lappeenranta 15
Los Angeles 14
Tianjin 13
Jiaxing 12
Norwalk 12
Haikou 11
Istanbul 11
Tehran 11
Busseto 10
Castelfranco Emilia 10
Redmond 10
Toronto 10
Zhengzhou 10
Hyderabad 9
Rome 9
Andover 8
Athens 8
Bühl 8
Monmouth Junction 8
Mülheim 8
Zanjan 8
Leawood 7
Fuzhou 6
Ningbo 6
North York 6
Olalla 6
Shanghai 6
Taiyuan 6
Taizhou 6
Vienna 6
Bo 5
Dearborn 5
Frankfurt am Main 5
Hong Kong 5
Jakarta 5
Kraków 5
Kunming 5
Lanzhou 5
Mahé 5
Sacramento 5
Washington 5
Augusta 4
Des Moines 4
Grafing 4
Romainville 4
Tappahannock 4
Tokyo 4
Wuhan 4
Xi'an 4
Atlanta 3
Totale 6.273
Salva come PNG Salva come JPEG
Nome #
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery 278
A Specific Pattern of Somatic Mutations Associates with Poor Prognosis Aneuploid Acute Myeloid Leukemia: Results from the European NGS-PTL Consortium 232
B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. 221
A NEW SUBSET OF ADULT B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENT WITH PREDNISONE-INDUCED MONOCYTIC DIFFERENTIATION? 218
Aggressive Aneuploid Acute Myeloid Leukemia Is Dependent on Alterations of P53, Gain of APC and PLK1 and Loss of RAD50 217
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 214
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis 199
Chromothripsis in acute myeloid leukemia: Biological features and impact on survival 190
Blinatumomab Is Safe and Effective in Relapsed and MRD Positive B-ALL CD19+ Patients: The Bologna Compassionate Program Experience 185
Alterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 183
A novel t(2;10)(q31;p12) balanced translocation in acute myeloid leukemia 172
Alterations of BRCA1 and PALB2 Define a Novel Class of Complex-Karyotype AML with a Very Bad Prognosis 169
Chromosome abnormalities additional to the Philadelphia chromosome at the diagnosis of chronic myelogenous leukemia: pathogenetic and prognostic implications. 165
A cell cycle-related genomic and transcriptomic signature distinguish aneuploid and euploid acute myeloid leukemia 156
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: Molecular cytogenetic characterization and influence on TKIs therapy 154
Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement:clinical implications 151
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) 147
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities 144
Epigenetically induced ectopic expression of uncx impairs the proliferation and differentiation of myeloid cells 141
BCR-ABL1-Positive Acute Lymphoblastic Leukemia Patients Treated with Only TKI Vs Conventional Chemo Plus TKI Therapy Show Similar DNA Alterations At Relapse Targeting Key Regulators of Tumor Suppression, Cell Cycle Control, and Lymphoid/B-Cell Development 141
MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia 140
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response, a study of the GIMEMA CML WP. 138
Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results. 137
4q12 translocations with GSX2 expression identify a CD7+ acute myeloid leukaemia subset 135
Copy number variants signature in two patients with relapsed acute promyelocytic leukemia 129
Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients 127
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 127
Deficient necroptosis pathway as a negative prognostic factor in acute myeloid leukemia. 125
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival 123
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. 120
Very Poor Outcome and Chemoresistance of Acute Myeloid Leukemia Patients with TP53 Mutations: Correlation with Complex Karyotype and Clinical Outcome 120
Two or More Chemotherapy Consolidation Courses, Followed By Autologous Bone Marrow Transplantation, and MRD Negativity, Give Long Term Overall Survival in Acute Myeloid Leukemia Patients 120
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 118
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 118
Impact on survival of catastrophic karyotype events in 101 consecutive acute myeloid leukemia (AML) patients: High risk karyotype and chromothripsis 117
Gemtuzumab-Ozogamicin Containing Regimens As Induction Therapy Give the Highest Complete Remission Rate and the Longest Overall Survival Compared with Other Induction Regimens in Patients with Newly Diagnosed Acute Myeloid Leukemia 117
GAS1 AND KIF27 GENES ARE STRONGLY UP-REGULATED BIOMARKERS OF HEDGEHOG INHIBITION (PF-04449913) ON LEUKEMIA STEM CELLS IN PHASE I ACUTE MYELOID LEUKEMIA AND CHRONIC MYELOID LEUKEMIA TREATED PATIENTS 115
Dissecting the Molecular Mechanisms of Aneuploidy in Acute Myeloid Leukemia By Next Generation Sequencing 114
Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway 114
Microarray analysis to identifiy novel copy number alterations in acute myeloid leukemia 112
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 108
RNA Sequencing Reveals Novel and Rare Fusion Transcripts in Acute Myeloid Leukemia 108
Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy 108
EFFICACY, FEASIBILITY AND SAFETY OF NELARABINE SAVAGE THERAPY IN ADULT RELAPSED OR REFRACTORY T CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) OR LYMPHOBLASTIC LYMPHOMA (T-LBL): THE BOLOGNA EXPERIENCE 106
MHC-I Antigen Presentation Role in Immune Escape of Acute Myeloid Leukemia with High Burden of Genomic Aberration 105
A New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 105
Separase overexpression defines a new subset of acute myeloma leukemia patients characterized by high CD34 and MYC levels 103
Ponatinib Is Well Tolerated and Active In Patients With Relapsed/Refractory Philadelphia Positive Acute Lymphoblastic Leukemia (PH+ ALL) and Advanced Phase Of Chronic Myelogenous Leukemia (CML) Harbouring T315I Mutation: The Bologna Experience 101
FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features 100
Prognostic significance of alterations of pathways regulating autophagy in acute myeloid leukemia 100
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 96
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) 95
PKC412 (Midostaurin) is safe and highly effective in Systemic Mastocytosis patients: the Bologna experience 95
PKC412 (Midostaurin) Is Safe and Highly Effective in Systemic Mastocytosis Patients: The Bologna Experience 94
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 94
Genome-Wide Analysis by High-Resolution SNP Array Identifies Novel Genomic Alterations in Acute Promyelocytic Leukemia (APL). 93
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 92
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 91
Novel fusion transcripts identified by RNAseq cooperate with somatic mutations in the pathogenesis of acute myeloid leukemia 90
Leukemia Associated TP53 Mutations in AML Patients ARE Strongly Associated with Complex Karyotype and Poor Outcome 89
You have accessAlterations in Pathways Regulating Phosphatidil Inositol 3 Phosphate (PI3P) Produce Both Cell Proliferation and Therapy Resistance, and Define a Group of Patients with Poor Prognosis in Acute Myeloid Leukemia (AML) 88
You have accessA New Entity of Acute Myeloid Leukemia Driven By Epigenetic and Somatic Dis-Regulation of Uncx, a Novel Homeobox Transcription Factor Gene 86
Ponatinib is well tolerated and active in patients with relapsed/refractory philadelphia positive leukemias: The Bologna experience 83
Nelarabine Is Safe and Effective In Adult Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia (T-ALL) and Lymphoblastic Lymphoma (T-LBL): The Bologna Experience 83
Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome 83
IKZF1 (IKAROS) DELETIONS IN BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME 83
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 82
NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: BEYOND 4 YEARS RESULTS REMAIN STABLE - THE GIMEMA CML WP TRIAL CML0307 80
Next-Generation Sequencing Analysis Revealed That BCL11B Chromosomal Translocation Cooperates with Point Mutations in the Pathogenesis of Acute Myeloid Leukemia 79
Pharmacological interaction and side effects in oncohaematology: a retrospective observational study 75
NELARABINE IS SAFE AND EFFECTIVE IN ADULT RELAPSED OR REFRACTORY T CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL) AND LYMPHOBLASTIC LYMPHOMA (T-LBL): THE BOLOGNA EXPERIENCE 73
PKC412 (Midostaurin) is safe and highly effective in Systemic Mastocytosis patients: follow up of a single-center Italian compassionate use 71
IKZF1 (IKAROS) DELETIONS ARE INDEPENDENT ON THE PHILADELPHIA CHROMOSOME AND ARE ASSOCIATED WITH AN IMPAIRED B-CELL DIFFERENTIATION AND POOR OUTCOME IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS 66
SINGLE NUCLEOTIDE POLYMORPHISM (SNP) ARRAYS IDENTIFIED FREQUENT GENOMIC ABNORMALITIES IN GENES INVOLVED IN DRUG TRANSPORT AND INHIBITION OF APOPTOSIS IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS 66
IDENTIFICATION OF FREQUENT GENOMIC ABNORMALITIES IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS USING SINGLE NUCLEOTIDE POLYMORPHISM ARRAYS 62
IKZF1 (IKAROS) DELETIONS ARE A CENTRAL EVENT IN THE PATHOGENESIS OF BCR-ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA 62
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities 60
Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients 59
Impact of infectious comorbidity and overall time of hospitalization in total outpatient management of acute myeloid leukemia patients following venetoclax and hypomethylating agents 45
The baseline comorbidity burden affects survival in elderly patients with acute myeloid leukemia receiving hypomethylating agents: Results from a multicentric clinical study 22
Totale 9.524
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.145
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.145
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.685 0 0 0 139 209 195 234 228 294 162 120 104
2020/20211.604 209 55 42 33 31 66 34 94 120 57 74 789
2021/20221.862 252 43 101 180 179 103 37 95 95 150 328 299
2022/20231.979 220 311 118 258 134 159 47 108 329 49 153 93
2023/2024589 23 74 28 68 39 149 36 52 21 31 38 30
2024/2025591 71 297 177 46 0 0 0 0 0 0 0 0
Totale 9.524